Moreover, inhibition of ICR would attenuate fibrotic changes in TGF-β1-induced proximal tubular cells potentially through Akt/mTOR signaling pathway, which points to a novel anti-fibrotic treatment in renal diseases. The gene discussed is AKT1; the disease is kidney disorder.